SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-23-005799
Filing Date
2023-02-10
Accepted
2023-02-10 10:30:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10047835_sc13ga.htm SC 13G/A 66401
  Complete submission text file 0001140361-23-005799.txt   67887
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

IRS No.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SC 13G/A

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89674 | Film No.: 23609180
SIC: 2836 Biological Products, (No Diagnostic Substances)